Search
Close this search box.

IMPACT

Genome Atlantic has consistently strived to drive meaningful impact through all our activities. Realizing the importance of quantifying this impact, we recently enlisted The Evidence Network to conduct a comprehensive Impact Assessment spanning the five-year period from 2018 to 2023. Their findings pointed to a remarkable return on investment and tangible outcomes:

  • Every public sector dollar invested in Genome Atlantic yielded $23 in applied R&D investment and $59 to GDP.
  • Genome Atlantic’s efforts enabled $60 million in new impact-driven genomics R&D – of which $21 million or roughly 30%, was private sector investment.
  • Total funds attracted by and invested in Genome Atlantic during the last five years resulted in an estimated $178.7 million of output, $122.2 million contributions to GDP, $8.9 million in provincial and federal tax revenues, and 927 jobs.
  • The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

Featured Stories
End Of Issue #116

Sign up for our free newsletter.

We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.

Read recent issues here.

Sign up for our free newsletter.

We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.

Read recent issues here.